Compare Align Technology, Inc. (ALGN) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Raymond James Financial, Inc. — how do they compare? Align Technology, Inc. trades at $181.11 (market cap $12.86B), while Raymond James Financial, Inc. trades at $166.88 (market cap $32.76B). The key difference: Raymond James Financial, Inc. is far larger — about 2.5× Align Technology, Inc.'s market cap, and Raymond James Financial, Inc. pays a 1.28% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | RJF | |
|---|---|---|
Market Cap | $12.86B | $32.76B |
Sector | Health | Financials |
52-Week High | $207.19 | $176.43 |
52-Week Low | $124.88 | $140.89 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Raymond James Financial (RJF) trades at $168.12, down 0.36% today, with a bullish technical signal and strong earnings momentum after beating estimates in three consecutive quarters. Revenue growth is robust, with 2025 revenue reaching $13.84B and net income of $2.14B, though profit margins have moderated slightly. Analyst consensus is positive with a $176.83 price target, and the company maintains a solid dividend, recently declaring $0.54 per share payable in July 2026.
The outlook for RJF is favorable, supported by earnings beats and strategic investments, but risks include rising expenses and market volatility. Upside potential exists if cost management improves and revenue growth sustains, aligning with analyst targets. Key risks are competitive pressures and economic sensitivity, yet institutional sentiment remains bullish with no sell ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
